US Patent

US8703177 — Abuse-resistant mucoadhesive devices for delivery of buprenorphine

Formulation · Assigned to Biodelivery Sciences International Inc · Expires 2032-08-20 · 6y remaining

Vulnerability score 47/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects abuse-deterrent mucoadhesive devices for delivering buprenorphine, specifically designed to maximize its absorption.

USPTO Abstract

The present invention provides abuse deterrent mucoadhesive devices for delivery of buprenorphine. Each device comprises a mucoadhesive layer and a backing layer, and the pH in each layer is selected, such that absorption of buprenorphine is maximized.

Drugs covered by this patent

Patent Metadata

Patent number
US8703177
Jurisdiction
US
Classification
Formulation
Expires
2032-08-20
Drug substance claim
No
Drug product claim
Yes
Assignee
Biodelivery Sciences International Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.